Prev
An attorney seeking as much as $400 million in damages from two large pharmaceutical companies told jurors Tuesday the firms defrauded Alabama's Medicaid program with high prices for drugs for more than a decade. The trial, expected to last about two weeks, is the second to be held on more than 70 lawsuits filed by the state accusing pharmaceutical companies of overcharging Medicaid for prescription drugs. The first ended with a jury awarding the state $215 million against AstraZeneca Pharmaceuticals LP.
Investors might find it easier to sue insurance agents and carriers, thanks to new standards from the Certified Financial Planner Board of Standards Inc., attorneys said.
The Alabama Supreme Court ruled Friday that more than one pharmaceutical company can be tried at the same time in the state's lawsuit accusing more than 70 drug companies of fraud in overcharging the state's Medicaid program.
(Bloomberg) -- GlaxoSmithKline Plc and Novartis AG must face trial together in a lawsuit in which Alabama accuses them of inflating drug prices, costing the state Medicaid program $130 million in overcharges, the Alabama Supreme Court ruled.
A federal judge ruled the Justice Department can subpoena documents and question Countrywide Financial Corp. executives under oath to determine whether the lender abused borrowers and the bankruptcy-court process.
It is recommended that policyholders contact an attorney for legal advice immediately to determine if they should opt out. If policyholders do not opt out by the June 3 deadline, they will not be able to pursue individual litigation if they feel the class action decision is not an adequate remedy or if they file a claim on the policy in the future.
Beasley Allen Law Firm, 218 Commerce Street, Montgomery, AL 36104
Use of this website signifies your agreement to the Terms of Use and Privacy Policy.
